No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
40 (estimated)
Sponsor
Juan Carlos Cardet · Other
Who this trial is looking for
This trial is looking for adults with asthma who have been to the emergency room for an asthma attack. Participants will either get a scheduled telehealth appointment with an asthma specialist before leaving the ER or receive standard care without a scheduled appointment.
Are You a Good Fit for This Trial?
You may be able to join if
I am 18 years old or older
I have been diagnosed with asthma for at least 1 year
I was seen in the ER for an asthma exacerbation
I have persistent asthma and am on controller therapy
I have had at least 1 asthma exacerbation in the past year
You may not be able to join if
I have seen an asthma specialist in the past year
I have another lung disease like COPD or interstitial lung disease
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
This study is testing a new way to help adults with asthma get follow up care after an emergency room (ER) visit for an asthma attack. Many people who come to the ER for asthma never see an asthma specialist afterward, even though specialists can offer treatments such as advanced inhalers or biologic medicines that may prevent future attacks.
The study will compare two approaches. One group will …
This study is testing a new way to help adults with asthma get follow up care after an emergency room (ER) visit for an asthma attack. Many people who come to the ER for asthma never see an asthma specialist afterward, even though specialists can offer treatments such as advanced inhalers or biologic medicines that may prevent future attacks.
The study will compare two approaches. One group will receive a telehealth appointment with an asthma specialist that is scheduled for them before they leave the ER. The other group will receive the usual care, which typically includes a standard referral but no scheduled appointment. All participants will be offered a prescription for standard controller medication at discharge.
The main question the study aims to answer is whether arranging a telehealth visit directly from the ER increases the number of patients who complete a follow up appointment with an asthma specialist within three months. The study will also look at whether this approach improves asthma control, reduces repeat ER visits, and helps patients better understand and use their asthma medications.
This research may help identify a practical way to improve access to asthma specialists and reduce the burden of asthma for patients who frequently rely on emergency care.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Age ≥18 years
* Asthma diagnosis ≥1 year
* Seen in ER for asthma exacerbation
* Persistent asthma on controller therapy
* ≥1 asthma exacerbation in prior year
Exclusion Criteria:
* Patients who have seen an asthma specialist (allergist or pulmonologist) for asthma in the pas…
Inclusion Criteria:
* Age ≥18 years
* Asthma diagnosis ≥1 year
* Seen in ER for asthma exacerbation
* Persistent asthma on controller therapy
* ≥1 asthma exacerbation in prior year
Exclusion Criteria:
* Patients who have seen an asthma specialist (allergist or pulmonologist) for asthma in the past 1 year
* Diagnosis of other pulmonary diseases (e.g., COPD, interstitial lung disease, etc.)
We will allow for current smokers, vapers and cannabis users as long as they meet one of the COPD-allowable pathways below.
COPD-allowable pathways:
If none of the below are satisfied, then exclude for COPD.
Documentation: PFTs must be within 36 months of enrollment date; smoking history must be calculated and entered in this form based on patient input. Pack- year history will be collected for characterization/analysis but will not determineeligibility.
We will allow for COPD as long as they are:
* never smokers/vapers/cannabis users;
* former or current smokers/vapers/cannabis users with normal PFTs with FEV1/FVC \>=70% documented in a medical record within 36 months of the enrollment date
* former or current smoker/vapers/cannabis users with obstruction noted on PFTs (i.e., FEV1/FVC \<70%) but who demonstrates BOTH acute bronchodilator reversibility (i.e., \>10% increase in either FEV1%predicted or FVC% predicted) AND have a normal diffusing capacity (DLCO)
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.
